Shilei Zhao

1.1k total citations
52 papers, 776 citations indexed

About

Shilei Zhao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Shilei Zhao has authored 52 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Nephrology. Recurrent topics in Shilei Zhao's work include RNA modifications and cancer (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer-related molecular mechanisms research (6 papers). Shilei Zhao is often cited by papers focused on RNA modifications and cancer (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer-related molecular mechanisms research (6 papers). Shilei Zhao collaborates with scholars based in China, Japan and United States. Shilei Zhao's co-authors include Chundong Gu, Shi-Yao Wei, Wendan Yu, Wuguo Deng, Fengzhou Li, Qiuju Wei, Wei Guo, Xiaohong Chen, Zhuoshi Li and Qi Zhou and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Shilei Zhao

47 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilei Zhao China 19 447 155 137 122 95 52 776
Minseob Eom South Korea 14 352 0.8× 121 0.8× 104 0.8× 127 1.0× 172 1.8× 45 797
In Hee Lee South Korea 14 424 0.9× 101 0.7× 94 0.7× 58 0.5× 182 1.9× 55 920
Congwei Luo China 16 529 1.2× 211 1.4× 272 2.0× 99 0.8× 38 0.4× 22 1.0k
Jiao Mu China 17 522 1.2× 150 1.0× 137 1.0× 58 0.5× 62 0.7× 37 931
Laura Martínez‐Arias Spain 11 234 0.5× 88 0.6× 240 1.8× 99 0.8× 47 0.5× 17 605
Renuga Devi Rajaram Switzerland 14 474 1.1× 127 0.8× 88 0.6× 124 1.0× 309 3.3× 16 880
Yan Dai China 15 431 1.0× 128 0.8× 295 2.2× 51 0.4× 53 0.6× 27 884
Yoshiki Higashijima Japan 14 362 0.8× 69 0.4× 164 1.2× 58 0.5× 71 0.7× 24 729

Countries citing papers authored by Shilei Zhao

Since Specialization
Citations

This map shows the geographic impact of Shilei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Zhao more than expected).

Fields of papers citing papers by Shilei Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Zhao. The network helps show where Shilei Zhao may publish in the future.

Co-authorship network of co-authors of Shilei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Shilei Zhao. A scholar is included among the top collaborators of Shilei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilei Zhao. Shilei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Yuting, Jia Li, Qing Geng, et al.. (2025). Screening and functional characterization of nanobodies targeting the transferrin receptor. Protein Expression and Purification. 231. 106702–106702. 1 indexed citations
2.
Li, Zhuoshi, Shiqing Wang, Shilei Zhao, et al.. (2025). PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 Upregulation. Cancer Biotherapy and Radiopharmaceuticals. 40(8). 567–579.
3.
Xu, Xiaolin, et al.. (2025). Leiomyosarcomas of the inferior vena cava: diagnostic features on contrast-enhanced CT, ultrasonography and MRI. Frontiers in Oncology. 15. 1442674–1442674. 1 indexed citations
4.
Chen, Junlin, Shilei Zhao, Chengjian He, et al.. (2025). P23 acts as a negative regulator of ferroptosis in NSCLC by blocking GPX4 degradation via chaperone-mediated autophagy. Molecular Cancer. 24(1). 234–234.
5.
6.
Zhang, Xu, Zi‐Han Zhang, Yongmin Liu, et al.. (2025). Investigating lung cancer microenvironment from cell segmentation of pathological image and its application in prognostic stratification. Scientific Reports. 15(1). 1704–1704. 2 indexed citations
7.
Zheng, Wang, Qifeng Zhang, Shilei Zhao, et al.. (2024). Veno-venous extracorporeal membrane oxygenation-assisted treatment of severe airway stenosis due to goiter: Two case reports. Medicine. 103(36). e39506–e39506. 1 indexed citations
8.
Zhang, Yixiang, et al.. (2024). Genomic heterogeneity of multiple synchronous lung cancers in Chinese population. Cancer Medicine. 13(2). e6928–e6928. 2 indexed citations
9.
10.
Wang, Feiyu, Shilei Zhao, Xuewen Xu, et al.. (2021). Integrating LCM-Based Spatio-Temporal Transcriptomics Uncovers Conceptus and Endometrial Luminal Epithelium Communication that Coordinates the Conceptus Attachment in Pigs. International Journal of Molecular Sciences. 22(3). 1248–1248. 12 indexed citations
11.
Zhao, Shilei, Xin Guo, Kenichi Mizutani, et al.. (2021). Overexpression of Teashirt Homolog 2 suppresses cell proliferation and predicts the favorable survival of Lung Adenocarcinoma. International Journal of Medical Sciences. 18(9). 1980–1989. 4 indexed citations
12.
Cui, Lei, Qi Zhou, Xiufeng Zheng, Bowen Sun, & Shilei Zhao. (2020). Mitoquinone attenuates vascular calcification by suppressing oxidative stress and reducing apoptosis of vascular smooth muscle cells via the Keap1/Nrf2 pathway. Free Radical Biology and Medicine. 161. 23–31. 65 indexed citations
13.
14.
Zhao, Shilei, Xin Guo, Makoto Taniguchi, et al.. (2020). Detection of Mediastinal Lymph Node Metastases Using Indocyanine Green (ICG) Fluorescence Imaging in an Orthotopic Implantation Model. Anticancer Research. 40(4). 1875–1882. 4 indexed citations
15.
Guo, Tao, Shilei Zhao, Zhuoshi Li, et al.. (2018). Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma. Cancer Biomarkers. 22(2). 301–310. 7 indexed citations
16.
Tang, Ranran, Xiangdong Xu, Wenjing Yang, et al.. (2016). MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. Cancer Letters. 373(1). 77–87. 28 indexed citations
17.
Chen, Xiaohong, Shi-Yao Wei, Qingfang Zhang, et al.. (2016). Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction. PLoS ONE. 11(1). e0147084–e0147084. 50 indexed citations
18.
Zhao, Shilei, Yan Wang, Tao Guo, et al.. (2016). YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma. Oncotarget. 7(50). 82139–82157. 31 indexed citations
19.
Chen, Xiaohong, et al.. (2015). The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling. Journal of the Formosan Medical Association. 114(5). 430–437. 44 indexed citations
20.
Chen, Xiaohong, Lei Peng, Shi-Yao Wei, et al.. (2015). Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease. PLoS ONE. 10(9). e0137049–e0137049. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minseob Eom Breakdown of academic impact, for papers by In Hee Lee Breakdown of academic impact, for papers by Congwei Luo Breakdown of academic impact, for papers by Jiao Mu Breakdown of academic impact, for papers by Laura Martínez‐Arias Breakdown of academic impact, for papers by Renuga Devi Rajaram Breakdown of academic impact, for papers by Yan Dai Breakdown of academic impact, for papers by Yoshiki Higashijima
Rankless by CCL
2026